Related Experiment Video
Updated: Jul 25, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
476
Long Non-Coding RNAs as Emerging Targets in Lung Cancer
Jovanka Gencel-Augusto1,2, Wei Wu1,2, Trever G Bivona1,2,3
1Department of Medicine, University of California San Francisco (UCSF), San Francisco, CA 94158, USA.
Cancers
|June 28, 2023
Summary
Long non-coding RNAs (LncRNAs) are key regulators in lung cancer development and progression. Investigating these molecules offers new diagnostic and therapeutic strategies for this deadly disease.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Long non-coding RNAs (LncRNAs) are non-protein-coding transcripts longer than 200 nucleotides.
- LncRNAs are crucial for normal cellular functions and organism development.
- Dysregulated lncRNA activity is implicated in various diseases, including cancer.
Purpose of the Study:
- To review in vivo evidence of lncRNA roles in lung cancer.
- To explore lncRNAs as biomarkers for lung cancer diagnosis and prognosis.
- To discuss therapeutic strategies targeting lncRNAs in lung cancer.
Main Methods:
- Literature review of recent studies on lncRNAs in lung cancer.
- Focus on in vivo evidence for lncRNA functions.
- Analysis of lncRNA potential in diagnostics and therapeutics.
Main Results:
- LncRNAs exhibit significant roles in lung cancer development and progression.
- LncRNAs demonstrate oncogenic or tumor-suppressive functions in lung cancer.
- LncRNAs are stable in circulation, indicating potential as non-invasive biomarkers.
Conclusions:
- LncRNAs are vital in lung cancer initiation, development, and progression.
- Targeting lncRNAs presents a promising new therapeutic avenue for lung cancer.
- Integrating lncRNA research with protein-coding gene studies offers a holistic view of lung cancer.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
01:20Types of RNA
5.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.9K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:18Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:30siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K